As both TGF-β and WNT signaling pathways were dysregulated in the MPN MSC RNA-Seq and ATAC-Seq data, we designed in vitro studies to unravel the molecular actors of TGF-β/WNT signaling in MPN MSCs. This evidence concerns the gene TGFB1 and myeloproliferative neoplasm.